Ali Aboulwafa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ali Aboulwafa has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ahamed Lebbe
Medical Department, Weill Cornell Medicine-Qatar, Doha 24144, Qatar
1 shared publication - Beshr Mushannen
Medical Department, Weill Cornell Medicine-Qatar, Doha 24144, Qatar
1 shared publication - Dalia Zakaria
Department of Premedical Education, Weill Cornell Medicine-Qatar, Doha P.O. Box 24144, Qatar
1 shared publication - Ibrahim Mohammed
Department of Medicine, Albany Medical College, New York, NY 12208, USA
1 shared publication - Lina Yagan
Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
1 shared publication - Malik Mushannen
Department of Medicine, New York-Presbyterian Brooklyn Methodist Hospital, New York, NY 11215, USA
1 shared publication
Latest Publications
- Open Access
- 10 September 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (9) , 2065
New Onset of Acute and Chronic Hepatic Diseases Post-COVID-19 Infection: A Systematic Review
The SARS-CoV-2 virus caused a pandemic in the 2020s, which affected almost every aspect of life. As the world is recovering from the effect of the coronavirus, the concept of post-COVID-19 syndrome has emerged. Multiple organ systems have been implicated, including the liver. We aim to identify and analyze the reported cases of severe and long-term parenchymal liver injury post-COVID-19 infection. Several databases were used to conduct a comprehensive literature search to target studies reporting cases of severe and long-term parenchymal liver injury post-COVID-19 infection. Screening, data extraction, and cross checking were performed by two independent reviewers. Only 22 studies met our inclusion criteria. Our results revealed that liver steatosis, non-alcoholic fatty liver disease (NAFLD), and cirrhosis were the most reported liver associated complications post-COVID-19 infection. Moreover, complications like acute liver failure, hepatitis, and liver hemorrhage were also reported. The mechanism of liver injury post-COVID-19 infection is not fully understood. The leading proposed mechanisms include the involvement of the angiotensin-converting enzyme-2 (ACE-2) receptor expressed in the liver and the overall inflammatory state caused by COVID-19 infection. Future studies should incorporate longer follow-up periods, spanning several years, for better insight into the progression and management of such diseases.
- 10 September 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (9) , 2065
Open AccessNew Onset of Acute and Chronic Hepatic Diseases Post-COVID-19 Infection: A Systematic Review
The SARS-CoV-2 virus caused a pandemic in the 2020s, which affected almost every aspect of life. As the world is recovering from the effect of the coronavirus, the concept of post-COVID-19 syndrome has emerged. Multiple organ systems have been implicated, including the liver. We aim to identify and analyze the reported cases of severe and long-term parenchymal liver injury post-COVID-19 infection. Several databases were used to conduct a comprehensive literature search to target studies reporting cases of severe and long-term parenchymal liver injury post-COVID-19 infection. Screening, data extraction, and cross checking were performed by two independent reviewers. Only 22 studies met our inclusion criteria. Our results revealed that liver steatosis, non-alcoholic fatty liver disease (NAFLD), and cirrhosis were the most reported liver associated complications post-COVID-19 infection. Moreover, complications like acute liver failure, hepatitis, and liver hemorrhage were also reported. The mechanism of liver injury post-COVID-19 infection is not fully understood. The leading proposed mechanisms include the involvement of the angiotensin-converting enzyme-2 (ACE-2) receptor expressed in the liver and the overall inflammatory state caused by COVID-19 infection. Future studies should incorporate longer follow-up periods, spanning several years, for better insight into the progression and management of such diseases.